Published in PLoS One on October 17, 2011
Promises and challenges of MicroRNA-based treatment of multiple myeloma. Curr Cancer Drug Targets (2012) 1.26
De-regulated microRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and development. PLoS One (2013) 1.06
Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle (2013) 1.01
MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs. PLoS One (2012) 0.99
MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα. Lipids Health Dis (2013) 0.90
Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int (2014) 0.90
The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer. Oncotarget (2016) 0.86
Impaired DICER1 function promotes stemness and metastasis in colon cancer. Oncogene (2013) 0.86
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci (2014) 0.84
The miR-310/13 cluster antagonizes β-catenin function in the regulation of germ and somatic cell differentiation in the Drosophila testis. Development (2013) 0.84
Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol (2012) 0.84
microRNA regulation of Wnt signaling pathways in development and disease. Cell Signal (2015) 0.84
Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Mol Cancer (2016) 0.82
The miR-1-NOTCH3-Asef pathway is important for colorectal tumor cell migration. PLoS One (2013) 0.81
MiR218 Modulates Wnt Signaling in Mouse Cardiac Stem Cells by Promoting Proliferation and Inhibiting Differentiation through a Positive Feedback Loop. Sci Rep (2016) 0.77
WNT signaling suppression in the senescent human thymus. J Gerontol A Biol Sci Med Sci (2014) 0.77
miR-21 Reduces Hydrogen Peroxide-Induced Apoptosis in c-kit(+) Cardiac Stem Cells In Vitro through PTEN/PI3K/Akt Signaling. Oxid Med Cell Longev (2016) 0.77
microRNAs regulate β-catenin of the Wnt signaling pathway in early sea urchin development. Dev Biol (2015) 0.76
MicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway. PLoS One (2016) 0.75
miR-21 increases c-kit(+) cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling. PeerJ (2017) 0.75
Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials. Cancers (Basel) (2016) 0.75
MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell (2010) 17.87
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature (2009) 14.07
Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature (2008) 9.83
Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol (2002) 8.60
Functional genomic analysis of the Wnt-wingless signaling pathway. Science (2005) 4.73
MicroRNA-125b is a novel negative regulator of p53. Genes Dev (2009) 4.43
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A (2008) 3.77
MiRNAs and cancer. Am J Pathol (2009) 3.42
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
Cell cycle control of wnt receptor activation. Dev Cell (2009) 2.52
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology (2009) 2.35
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem (2009) 2.24
Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther (2008) 2.07
MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood (2009) 2.07
Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol (2009) 2.06
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene (2005) 2.06
ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer (1995) 1.94
Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell (2010) 1.92
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci U S A (2004) 1.89
Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci (2006) 1.78
Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene (2010) 1.78
The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A (2008) 1.76
Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets (2004) 1.72
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun (2009) 1.61
Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells. Cancer Biol Ther (2007) 1.57
Biochemical principles of small RNA pathways. Annu Rev Biochem (2010) 1.54
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia (2004) 1.54
Functional screening identifies miR-315 as a potent activator of Wingless signaling. Proc Natl Acad Sci U S A (2007) 1.53
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A (2010) 1.47
MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Lett (2009) 1.40
Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer. Cancer Res (2008) 1.36
MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One (2009) 1.33
Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol (2008) 1.26
Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest (2009) 1.24
Regulation of zebrafish fin regeneration by microRNAs. Proc Natl Acad Sci U S A (2008) 1.23
CK1epsilon is required for breast cancers dependent on beta-catenin activity. PLoS One (2010) 1.22
miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun (2010) 1.21
Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis. Oncogene (2009) 1.21
Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun (2008) 1.20
PCAF acetylates {beta}-catenin and improves its stability. Mol Biol Cell (2008) 1.18
The internally truncated LRP5 receptor presents a therapeutic target in breast cancer. PLoS One (2009) 1.12
Impact of tiny miRNAs on cancers. World J Gastroenterol (2007) 1.08
Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin. Clin Exp Metastasis (2003) 1.07
Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Carcinogenesis (1999) 1.05
Involvement of microRNAs in breast cancer. Semin Reprod Med (2008) 0.99
Kinases and G proteins join the Wnt receptor complex. Bioessays (2006) 0.88
Growth inhibition effect of β-catenin small interfering RNA-mediated gene silencing on human colon carcinoma HT-29 cells. Cancer Biother Radiopharm (2010) 0.78
Octreotide inhibits growth of colonic cancer SW480 cells by modulating the Wnt/P-catenin pathway. Pharmazie (2009) 0.78
Functional genomics reveals genes involved in protein secretion and Golgi organization. Nature (2006) 3.72
Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell (2012) 2.35
Untangling desmosomal knots with electron tomography. Science (2003) 2.25
Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia (2003) 1.68
The Wingless morphogen gradient is established by the cooperative action of Frizzled and Heparan Sulfate Proteoglycan receptors. Dev Biol (2004) 1.35
MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One (2009) 1.33
A membrane-associated β-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells. Development (2013) 1.26
Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res (2010) 1.24
Gli3-mediated repression of Hedgehog targets is required for normal mammary development. Development (2006) 1.23
Dissecting the roles of beta-catenin and cyclin D1 during mammary development and neoplasia. Proc Natl Acad Sci U S A (2003) 1.08
Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proc Natl Acad Sci U S A (2013) 1.01
Bone morphogenetic protein signaling regulates postnatal hair follicle differentiation and cycling. Am J Pathol (2004) 0.98
Plakoglobin is required for effective intermediate filament anchorage to desmosomes. J Invest Dermatol (2008) 0.97
Beta-catenin and cyclin D1: connecting development to breast cancer. Cell Cycle (2004) 0.94
Plakoglobin is O-glycosylated close to the N-terminal destruction box. J Biol Chem (2003) 0.93
Choreographing metastasis to the tune of LTBP. J Mammary Gland Biol Neoplasia (2011) 0.90
Bili inhibits Wnt/beta-catenin signaling by regulating the recruitment of axin to LRP6. PLoS One (2009) 0.89
The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor. Development (2007) 0.85
Yan, an ETS-domain transcription factor, negatively modulates the Wingless pathway in the Drosophila eye. EMBO Rep (2011) 0.84
PAPTi: a peptide aptamer interference toolkit for perturbation of protein-protein interaction networks. Sci Rep (2013) 0.84
Molecular cloning of the mouse Ltbp-1 gene reveals tissue specific expression of alternatively spliced forms. Gene (2003) 0.82
A mouse transgenic approach to induce β-catenin signaling in a temporally controlled manner. Transgenic Res (2010) 0.80
Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma. Anticancer Res (2012) 0.79
Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer. Breast Cancer Res Treat (2010) 0.77
Links between transforming growth factor-beta and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity. Breast Cancer Res (2009) 0.76
HIV's Nef interacts with β-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One (2013) 0.76
Gli activity is critical at multiple stages of embryonic mammary and nipple development. PLoS One (2013) 0.76
Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution. Breast Cancer Res (2013) 0.75
Luciferase reporter assay in Drosophila and mammalian tissue culture cells. Curr Protoc Chem Biol (2014) 0.75
Adhesion G-protein-coupled receptors: elusive hybrids come of age. Cell Commun Adhes (2013) 0.75
Highlights from special issue: junctional targets of skin and heart diseases. Cell Commun Adhes (2014) 0.75